Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1200P (RNA, U6 small nuclear 1200, pseudogene) is a pseudogene member of the U6 small nuclear RNA family, classified as a non-coding RNA, with no evidence supporting a direct therapeutic target role or involvement in drug interactions. RNU6-1200P (RNA, U6 small nuclear 1200, pseudogene) is a human pseudogene variant derived from the U6 small nuclear RNA gene family. U6 small nuclear RNAs (snRNAs) are a highly conserved group of non-coding RNAs involved in the catalytic core of the spliceosome, essential for intron removal from pre-mRNA during splicing[1][3]. The human genome contains hundreds of U6 snRNA gene copies and many U6-derived pseudogenes, reflecting the evolutionary importance of the U6 sequence[2][3]. Pseudogenes like RNU6-1200P lack canonical function—they do not produce functional RNA, do not assemble into spliceosomal complexes, and have not been implicated as regulators, biomarkers, or therapeutic targets[5]. Their primary significance is as genomic relics of functionally active U6 genes[3][5]. No drugs, disease roles, or safety considerations are applicable to this transcript.
None (not a known drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1200, pseudogene (RNU6-1200P).